TAP Stock Analysis: Molson Coors Brewing | NYSE
Beverages - Brewers | NYSE, USA | Market Cap: 7.874m USD | 12M Return: -11.1% | US60871R2094 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 126M
EPS Trend: -72.2%
Qual. Beats: 0
Rev. Trend: -93.3%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Molson Coors Beverage Company is a global beverage producer that manufactures, markets, distributes, and sells beer and other malt beverage products across the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates a tiered brand portfolio spanning above-premium, premium, and economy price points, with flagship brands including Coors Light, Miller Lite, Molson Canadian, Blue Moon, Corona Extra, Stella Artois, Peroni Nastro Azzurro, Becks, and Pilsner Urquell.
Beyond traditional beer, the company has expanded into adjacent beverage categories such as hard seltzers (Topo Chico Hard Seltzer, Vizzy), craft beer, spirits (Blue Run Spirits), cider (Aspall, Rekorderlig), ready-to-drink beverages, premium mixers (Fever-Tree), and energy drinks (ZOA Energy). Originally founded in 1774 and headquartered in Golden, Colorado, the company rebranded from Molson Coors Brewing Company to Molson Coors Beverage Company in January 2020 to reflect its broader product diversification beyond beer. As a major player in the Brewers sub-industry of Consumer Staples, Molson Coors relies on a brand-licensing and distribution model, including partnerships with other major brewers such as Heineken, to extend its global reach.
- US beer volume declines amid shifting consumer preferences toward spirits and RTDs
- Input cost inflation and aluminum pricing pressure gross margins
- Premium portfolio expansion with ZOA Energy and Fever-Tree mixers diversifies revenue
| Net Income: 892.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 0.39 > 1.0 |
| NWC/Revenue: -4.34% < 20% (prev -18.86%; Δ 14.52% < -1%) |
| CFO/TA 0.08 > 3% & CFO 1.82b > Net Income 892.8m |
| Net Debt (5.65b) to EBITDA (2.01b): 2.81 < 3 |
| Current Ratio: 0.86 > 1.5 & < 3 |
| Outstanding Shares: last quarter (186.8m) vs 12m ago -5.61% < -2% |
| Gross Margin: 35.07% > 18% (prev 38.74%; Δ -3.66% > 0.5%) |
| Asset Turnover: 48.54% > 50% (prev 49.03%; Δ -0.49% > 0%) |
| Interest Coverage Ratio: 5.60 > 6 (EBIT TTM 1.26b / Interest Expense TTM 225.6m) |
| A: -0.02 (Total Current Assets 2.84b - Total Current Liabilities 3.32b) / Total Assets 22.6b |
| B: 0.27 (Retained Earnings 6.11b / Total Assets 22.6b) |
| C: 0.06 (EBIT TTM 1.26b / Avg Total Assets 22.7b) |
| D: 0.85 (Book Value of Equity 10.2b / Total Liabilities 12.1b) |
| Altman-Z'' = 2.01 = BBB |
| DSRI: 0.98 (Receivables 959.0m/993.8m, Revenue 11.0b/11.2b) |
| GMI: 1.10 (GM 38.74% / 35.07%) |
| AQI: 1.00 (AQ_t 0.66 / AQ_t-1 0.66) |
| SGI: 0.98 (Revenue 11.0b / 11.2b) |
| TATA: -0.04 (NI 892.8m - CFO 1.82b) / TA 22.6b) |
| Beneish M = -2.96 (Cap -4..+1) = A |
As of November 10, 2026, the stock is trading at USD 39.85 with a total of 4,494,479 shares traded. Over the past week, the price has changed by -7.82%, over one month by +7.12%, over three months by -5.19% and over the past year by -11.09%.
Current recommended Stop Loss: 37.20 (which is 6.6% or 1.8 ATR below the current price).
Molson Coors Brewing has received a consensus analysts rating of 3.24. Therefore, it is recommended to hold TAP.
- StrongBuy: 4
- Buy: 2
- Hold: 11
- Sell: 3
- StrongSell: 1
| Analysts Target Price | 43.6 | 9.5% |
P/E Trailing = 9.1804
P/E Forward = 7.9302
P/S = 0.7104
P/B = 0.7949
P/EG = 3.9244
Revenue TTM = 11.0b USD
EBIT TTM = 1.26b USD
EBITDA TTM = 2.01b USD
Long Term Debt = 3.81b USD (from longTermDebt, last fiscal year)
Short Term Debt = 379.8m USD (from shortTermDebt, last quarter)
Debt = 6.25b USD (from shortLongTermDebtTotal, last quarter) + Leases 52.8m
Net Debt = 5.65b USD (calculated: Debt 6.25b - CCE 602.2m)
Enterprise Value = 13.5b USD (7.87b + Debt 6.25b - CCE 602.2m)
Interest Coverage Ratio = 5.60 (Ebit TTM 1.26b / Interest Expense TTM 225.6m)
EV/FCF = 11.56x (Enterprise Value 13.5b / FCF TTM 1.17b)
FCF Yield = 8.65% (FCF TTM 1.17b / Enterprise Value 13.5b)
FCF Margin = 10.59% (FCF TTM 1.17b / Revenue TTM 11.0b)
Net Margin = 8.09% (Net Income TTM 892.8m / Revenue TTM 11.0b)
Gross Margin = 35.07% ((Revenue TTM 11.0b - Cost of Revenue TTM 7.17b) / Revenue TTM)
Gross Margin QoQ = 35.21% (prev 34.34%)
Tobins Q-Ratio = 0.60 (Enterprise Value 13.5b / Total Assets 22.6b)
Interest Expense / Debt = 3.61% (Interest Expense 225.6m / Debt 6.25b)
Taxrate = 22.10% (240.1m / 1.09b)
NOPAT = 983.8m (EBIT 1.26b * (1 - 22.10%))
Current Ratio = 0.86 (Total Current Assets 2.84b / Total Current Liabilities 3.32b)
Debt / Equity = 0.61 (Debt 6.25b / totalStockholderEquity, last quarter 10.2b)
Debt / EBITDA = 2.81 (Net Debt 5.65b / EBITDA 2.01b)
Debt / FCF = 4.83 (Net Debt 5.65b / FCF TTM 1.17b)
Total Stockholder Equity = 10.2b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.93% (Net Income 892.8m / Total Assets 22.6b)
RoE = 8.78% (Net Income TTM 892.8m / Total Stockholder Equity 10.2b)
RoCE = 9.04% (EBIT 1.26b / Capital Employed (Equity 10.2b + L.T.Debt 3.81b))
RoIC = 5.15% (NOPAT 983.8m / Invested Capital 19.1b)
WACC = 4.19% (E(7.87b)/V(14.1b) * Re(5.28%) + D(6.25b)/V(14.1b) * Rd(3.61%) * (1-Tc(0.22)))
Discount Rate = 5.28% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -99.11 | Cagr: -5.23%
[DCF] Terminal Value 76.31% ; FCFF base≈1.14b ; Y1≈1.21b ; Y5≈1.43b
[DCF] Fair Price = 94.07 (EV 22.0b - Net Debt 5.65b = Equity 16.4b / Shares 174.1m; r=8.35% [WACC [floored]]; 5y FCF grow 6.93% → 2.50% )
EPS Correlation: -72.20 | EPS CAGR: -4.87% | SUE: -0.06 | # QB: 0
Revenue Correlation: -93.27 | Revenue CAGR: -2.93% | SUE: -0.20 | # QB: 0
EPS current Quarter (2027-03-31): EPS=0.53 | Chg30d=-3.92% | Revisions=-70% | Analysts=11
EPS current Year (2026-12-31): EPS=4.69 | Chg30d=-0.59% | Revisions=-55% | GrowthEPS=-13.4% | GrowthRev=-0.8%
EPS next Year (2027-12-31): EPS=4.79 | Chg30d=-2.07% | Revisions=-55% | GrowthEPS=+2.1% | GrowthRev=+0.0%
[Analyst] Revisions Ratio: -73% (up=2, down=21)